Related Experiment Videos
[Virilizing and feminizing adrenal syndrome].
1Department of Urology, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|February 5, 2002
Summary
This study reviews diagnosing and treating adrenal syndromes. Key findings include differentiating benign from malignant adrenal tumors and tailoring congenital adrenal hyperplasia (CAH) treatments.
Area of Science:
- Endocrinology
- Oncology
- Pediatrics
Context:
- Adrenal syndromes, including virilizing and feminizing types, present complex diagnostic and therapeutic challenges.
- Distinguishing between benign and malignant sex hormone-producing adrenal neoplasms is critical for patient management.
- Congenital adrenal hyperplasia (CAH) requires specific treatment strategies based on the underlying enzyme deficiency.
Purpose:
- To investigate the diagnosis, differential diagnosis, and treatment of virilizing and feminizing adrenal syndromes.
- To differentiate benign from malignant sex hormone-producing adrenal neoplasms.
- To outline treatment principles for congenital adrenal hyperplasia (CAH).
Summary:
- The study analyzed 8 cases of CAH (including rare 17 alpha hydroxylase deficiency) and 5 cases of sex hormone-producing adrenal neoplasms (3 feminizing, 2 virilizing).
- Tumor characteristics (weight, diameter, DHEA, 17-ks, sex hormone levels, CT imaging, metastasis) correlate with malignancy.
- Surgical resection with a modified subcostal incision is recommended for large adrenal masses; CAH treatment varies by type, and sex hormone therapy is contraindicated in children with 17 hydroxylase deficiency before puberty.
Impact:
- Provides insights into differentiating adrenal neoplasms, aiding surgical planning and treatment decisions.
- Highlights the importance of individualized treatment for CAH based on specific deficiencies.
- Emphasizes the need for long-term follow-up due to the limitations of current diagnostic standards.